# Recursion Pharmaceuticals, Inc. (RXRX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/RXRX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 6.47M | $ -117.50M | $ -81.36M | $ 72.38M | $ 1.02B |
| 2025 | $ 76.34M | $ -660.18M | $ -387.32M | $ 77.97M | $ 1.13B |
| 2024 | $ 61.48M | $ -487.17M | $ -395.44M | $ 108.49M | $ 1.03B |
| 2023 | $ 47.44M | $ -354.72M | $ -324.73M | $ 50.67M | $ 463.44M |
| 2022 | $ 44.33M | $ -267.52M | $ -135.04M | $ 51.01M | $ 485.81M |
| 2021 | $ 11.89M | $ -221.66M | $ -235.84M | $ 11.48M | $ 542.94M |
| 2020 | $ 4.35M | $ -110.84M | $ -66.42M | $ 15.66M | $ -206.29M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.07 |
| Liabilities / Eq | 0.31 |
| Current Ratio | 5.47 |

## Other views

- [Metrics](https://sponda.capital/en/RXRX.md)
- [Charts](https://sponda.capital/en/RXRX/charts.md)
- [Compare](https://sponda.capital/en/RXRX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.